Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARDELYX, INC.ARDX · Entity 4972 | Chief Operating Officer | January 16, 2018 | January 18, 2018 |
| CareDx, Inc.CDNA · Entity 4344 | Director · See Remarks | October 02, 2023 | October 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARDELYX, INC.
Report date January 16, 2018 · Filed January 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.10 · Expires 2028-01-16 | Direct | 146,381 |
Reported balance
After 2018-01-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-01-16 · Grant · Acquired 146,381 · Balance 146,381 F1: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
CareDx, Inc.
Report date October 02, 2023 · Filed October 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 479,164 |
Reported balance
After 2023-10-02 transaction · row 1
1 source rowRow 1 · 2023-10-02 · Sale · Disposed 2,818 · Balance 479,164 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2022. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.83 to $6.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2022.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.83 to $6.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,821 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · derivative · entry 13 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,048 Underlying: Common Stock · 10,821 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| August 11, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 10,821 | $27.72 | $299,958.12 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 8 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 17:49 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 592 | $81.54 | $48,271.68 |
DisclosureSEC source: 0001217234-21-000198 · wf-form4_162863214140831.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,371 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · balance_after: Includes 329 shares acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 19:28 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,400 | $86.61 | $121,249.66 |
DisclosureSEC source: 0001217234-21-000174 · wf-form4_162587329843386.xml · nonDerivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,634 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.32 to $86.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 19:28 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,714 | $85.74 | $232,689.40 |
DisclosureSEC source: 0001217234-21-000174 · wf-form4_162587329843386.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,034 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.30 to $86.25, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 19:28 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,880 | $84.87 | $159,564.25 |
DisclosureSEC source: 0001217234-21-000174 · wf-form4_162587329843386.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,748 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.28 to $85.21, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 18:31 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 4,006 | $90.63 | $363,063.78 |
DisclosureSEC source: 0001217234-21-000172 · wf-form4_162569707625571.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,628 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,667 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · derivative · entry 12 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 11,667 shares Expires 2029-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,545 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · derivative · entry 11 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,416 Underlying: Common Stock · 1,545 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 4,690 | $96.34 | $451,840.70 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 7 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,371 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 8,522 | $95.42 | $813,149.64 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 6 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,061 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 11,667 | $27.17 | $316,992.39 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 5 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 28, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 1,545 | $24.35 | $37,620.75 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 4 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 25, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,963 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · derivative · entry 10 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,869 Underlying: Common Stock · 5,963 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 25, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,247 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · derivative · entry 9 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,961 Underlying: Common Stock · 3,247 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 25, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 9,210 | $95.15 | $876,317.69 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,371 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 25, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 5,963 | $27.72 | $165,294.36 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 25, 2021 Filed Aug 17, 2021 18:59 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,247 | $24.35 | $79,064.45 |
DisclosureSEC source: 0001217234-21-000206 · wf-form4_162924113493011.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 19:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,602 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000154 · wf-form4_162466505504890.xml · derivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,832 Underlying: Common Stock · 10,602 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 19:51 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 10,602 | $95.31 | $1,010,513.73 |
DisclosureSEC source: 0001217234-21-000154 · wf-form4_162466505504890.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,634 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.01 to $95.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 19:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 10,602 | $27.72 | $293,887.44 |
DisclosureSEC source: 0001217234-21-000154 · wf-form4_162466505504890.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,792 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · derivative · entry 7 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,208 Underlying: Common Stock · 4,792 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,833 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · derivative · entry 6 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,167 Underlying: Common Stock · 5,833 shares Expires 2029-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,093 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · derivative · entry 5 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,434 Underlying: Common Stock · 6,093 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 16,718 | $90.01 | $1,504,818.94 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · nonDerivative · entry 4 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,634 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.15, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 4,792 | $24.35 | $116,685.20 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · nonDerivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 5,833 | $27.17 | $158,482.61 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:51 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 6,093 | $27.72 | $168,897.96 |
DisclosureSEC source: 0001217234-21-000135 · wf-form4_162344827897392.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:32 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000128 · wf-form4_162328513791390.xml · derivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,527 Underlying: Common Stock · 500 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 25% of the shares subject to the option shall vest on November 26, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:32 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 500 | $90.00 | $45,001.00 |
DisclosureSEC source: 0001217234-21-000128 · wf-form4_162328513791390.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,634 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:32 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 500 | $27.72 | $13,860.00 |
DisclosureSEC source: 0001217234-21-000128 · wf-form4_162328513791390.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:39 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,973 | $0.00 Strike: $27.72 | $0.00 |
DisclosureSEC source: 0001217234-21-000120 · wf-form4_162319194940385.xml · derivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,027 Underlying: Common Stock · 9,973 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:39 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 9,973 | $90.01 | $897,643.80 |
DisclosureSEC source: 0001217234-21-000120 · wf-form4_162319194940385.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,634 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.07, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 18:39 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 9,973 | $27.72 | $276,451.56 |
DisclosureSEC source: 0001217234-21-000120 · wf-form4_162319194940385.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,100 | $86.45 | $181,540.38 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 7 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,634 F4 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.205 to $86.875, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 6,504 | $85.64 | $557,000.61 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 6 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,734 F4 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.17 to $86.15, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,200 | $84.55 | $101,461.20 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 5 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,238 F4 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.98 to $84.975, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 600 | $83.32 | $49,992.78 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 4 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,438 F4 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.915 to $83.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 300 | $82.35 | $24,705.51 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,038 F4 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.76 to $82.735, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 8,450 | $79.26 | $669,747.00 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,338 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 16:23 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-21-000049 · wf-form4_161463379217231.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,788 F1 · shares: The reported securities were represented by restricted performance stock units that were granted on February 3, 2020, 100% of which vested on February 25, 2021 upon the achievement of the requisite performance criteria. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 19:21 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 29,500 | $0.00 Strike: $87.37 | $0.00 |
DisclosureSEC source: 0001217234-21-000036 · wf-form4_161257085087506.xml · derivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,500 Underlying: Common Stock · 29,500 shares Expires 2031-02-03 F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 3, 2022 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 19:21 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 29,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-21-000036 · wf-form4_161257085087506.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,788 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 3, 2022 and 1/4th of which shall vest on each anniversary thereafter. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 17:36 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,747 | $76.43 | $133,523.21 |
DisclosureSEC source: 0001217234-21-000030 · wf-form4_161230539297909.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,288 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. F2 · balance_after: These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021. Read SEC document |
| December 18, 2020 Filed Dec 18, 2020 20:40 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 150 | $70.04 | $10,506.00 |
DisclosureSEC source: 0001217234-20-000204 · wf-form4_160834201663179.xml · nonDerivative · entry 3 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,035 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 18, 2020 Filed Dec 18, 2020 20:40 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 560 | $68.80 | $38,525.37 |
DisclosureSEC source: 0001217234-20-000204 · wf-form4_160834201663179.xml · nonDerivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,185 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.58 to $69.50, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| December 18, 2020 Filed Dec 18, 2020 20:40 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 7,653 | $67.92 | $519,769.57 |
DisclosureSEC source: 0001217234-20-000204 · wf-form4_160834201663179.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,745 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.58 to $68.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 16:09 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 5,551 | $56.08 | $311,300.08 |
DisclosureSEC source: 0001628280-20-016906 · wf-form4_160677052851763.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,398 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units. Read SEC document |
| November 02, 2020 Filed Nov 2, 2020 18:39 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $47.96 | $0.00 |
DisclosureSEC source: 0001217234-20-000194 · wf-form4_160436033027518.xml · derivative · entry 2 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2030-11-02 F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on November 1, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| November 02, 2020 Filed Nov 2, 2020 18:39 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000194 · wf-form4_160436033027518.xml · nonDerivative · entry 1 Seeto Reginald · CIK 0001688485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,949 F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on November 1, 2021 and 1/4th of which shall vest on each anniversary thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.